Government-sponsored guideline organizations (n = 3) |
Canadian Task Force on Preventive Health Care (41) | 2018 | Screening | Pregnant women not at increased risk for asymptomatic bacteriuria | Screening for asymptomatic bacteriuria in pregnancy |
Committee to Advise on Tropical Medicine and Travel (42) | 2016 | Screening and drug management | Individuals with or at risk of disseminated strongyloidiasis | Prevention, assessment and management of disseminated strongyloidiasis |
National Advisory Committee on Immunization, Public Health Agency of Canada (43) | 2018 | Drug management | Adults and children | Influenza vaccination |
Disease or condition interest groups (n = 9) |
Canadian ADHD Resource Alliance (44) | 2018 | Screening and drug management | Patients with ADHD | Diagnosis and management of ADHD |
Canadian HIV Trials Network (45) | 2017 | Drug management | Adults who are at risk of acquiring HIV infection through sexual activity or injection drug use | HIV pre-exposure prophylaxis and non-occupational postexposure prophylaxis |
Canadian Network for Mood and Anxiety Treatments (46) | 2016 | Drug management | Adults with unipolar major depressive disorder | Management of major depressive disorder (pharmacologic treatments) |
Canadian Research Initiative in Substance Misuse (47) | 2018 | Drug management | Adults with opioid use disorders | Management of opioid use disorders |
Diabetes Canada (48) | 2018 | Drug management | Patients with diabetes | Prevention and management of cardiovascular disease |
Heart and Stroke Foundation of Canada (49) | 2018 | Screening and drug management | Children and adults with transient ischemic attack or ischemic stroke who are not candidates for immediate hyperacute thrombolysis treatment with intravenous alteplase or endovascular thrombectomy | Prevention of ischemic stroke recurrence through identification and management of modifiable vascular risk factors |
Hypertension Canada (50) | 2018 | Drug management | Pregnant women with hypertension | Management of hypertension in pregnancy |
Kidney Cancer Research Network of Canada (51) | 2017 | Screening and drug management | Patients with advanced kidney cancer | Management of advanced kidney cancer |
Thrombosis Canada (52) | 2016 | Drug management | Patients with deep vein thrombosis | Treatment of deep vein thrombosis |
Medical professional societies (n = 9) |
Association of Medical Microbiology and Infectious Disease Canada (53) | 2016 | Drug management | HIV-1 infected adults | Early antiretroviral therapy for HIV-1 |
Canadian Academy of Child and Adolescent Psychiatry (54) | 2016 | Drug management | Children and adolescents with depression and/or anxiety disorders | Use of SSRIs and SNRIs to manage depression and anxiety |
Canadian Association for the Study of the Liver (55) | 2018 | Screening and drug management | Adults with chronic HCV infection | Management of chronic hepatitis C |
Canadian Cardiovascular Society (56) | 2018 | Drug management | Patients with atrial fibrillation | Management of atrial fibrillation |
Canadian Ophthalmological Society (57) | 2017 | Screening and drug management | Children and adults with type 1 or type 2 diabetes, of all ethnic origins | Screening, diagnosis and management of diabetic retinopathy |
Canadian Paediatric Society (58) | 2018 | Drug management | Children and adolescents | Human papillomavirus vaccination |
Canadian Rheumatology Association (59) | 2018 | Screening and drug management | Children and adults with systemic lupus erythematosus | Assessment and monitoring of systemic lupus erythematosus |
Canadian Urological Association (60) | 2016 | Drug management | Patients with kidney stones | Evaluation and medical management of kidney stones |
Society of Obstetricians and Gynaecologists of Canada (61) | 2018 | Screening and drug management | Pregnant women | Prevention, screening and treatment of toxoplasmosis in pregnancy |